Organization
Hospital for Special Surgery & Weill Cornell Medical College, New York
1 abstract
Abstract
ANALYSIS OF OUTCOMES AFTER NON-MEDICAL SWITCHING OF ANTI–TUMOR NECROSIS FACTOR AGENTS Org: Hospital for Special Surgery & Weill Cornell Medical College, New York, AbbVie Inc., North Chicago, IL, Medicus Economics, LLC, Milton, University of Chicago Medicine, Chicago, United States,